丹卡瓦斯将是过去50年来最重要的查试验吗?
Neal M Dixit1, Edward Chau1, Saul Schaefer1
1Division of Cardiovascular Medicine, Department of Internal Medicine, UC Davis Health, Sacramento, CA, USA.
American journal of preventive cardiology
|September 10, 2024
概括
心血管疾病查试验显示了潜在的益处,特别是对年轻男性. 丹麦心血管查试验表明,冠状动脉评分可以显著改善结果并挽救生命.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 公共卫生 公共卫生
背景情况:
- 心血管疾病查试验历史上一直在努力证明所有原因死亡率的显著降低.
- 丹麦心血管查试验 (DANCAVAS) 旨在评估查对65-74岁男性死亡率的影响.
研究的目的:
- 评估心血管查在减少全因死亡率方面的有效性.
- 分析子组差异,并确定特定年龄组查的潜在好处.
- 突出冠状动脉评分在心血管风险评估中的重要性.
主要方法:
- 随机对照试验设计比较选与未选的65-74岁男性.
- 作为主要结局,所有原因死亡率的临时分析.
- 小组分析侧重于年轻的参与者 (65-69岁).
主要成果:
- 五年间期分析没有显示出所有原因死亡率的统计显著降低 (危险比率:0.95,信心区间:0.90-1.00).
- 在65-69岁男性小组中观察到显著的益处,所有原因死亡率的危险比率较低 (0.89,CI 0.83-0.96).
- 查和未查组之间的结果差异越来越大,这表明潜在的长期益处.
结论:
- 虽然整个试验在中间分析中没有达到所有原因死亡率的统计学意义,但子组发现表明年轻男性的好处.
- 该试验有望变得有影响力,强调冠状动脉评分的关键作用.
- 实施冠状动脉评分可能是改善心血管健康和降低死亡率的关键策略.
相关概念视频
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...


